WPI MINOCYCLINE 75
Pill imprint WPI MINOCYCLINE 75 has been identified as Minocycline hydrochloride 75 mg.
Minocycline is used in the treatment of acne; rosacea; bacterial infection; skin and structure infection; skin infection (and more), and belongs to the drug class tetracyclines. There is positive evidence of human fetal risk during pregnancy.
Minocycline 75 mg is not subject to the Controlled Substances Act.
See also related documents.
Minocycline hydrochloride Images
- Imprint:
-
WPI
MINOCYCLINE 75 - Strength:
- 75 mg
- Color:
- White & Yellow
- Size:
- 16.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Tetracyclines
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Watson Pharmaceuticals
- National Drug Code (NDC):
- 00591-3153
- Inactive Ingredients:
- magnesium stearate
corn starch
D&C Red No. 28
D&C Yellow No. 10
gelatin
silicon dioxide
sodium lauryl sulfate
titanium dioxide
Advertisement
More Minocycline Hydrochloride resources
- Minocycline
- Minocycline (Wolters Kluwer)
- Minocycline Capsules (Wolters Kluwer)
- Minocycline Extended-Release Tablets (Wolters Kluwer)
- Minocycline Injection (Wolters Kluwer)
- Minocycline Pellet-Filled Capsules (Wolters Kluwer)
- minocycline (Cerner Multum)
- Arestin eent (AHFS DI)
- Minocycline Hydrochloride (AHFS DI)
- Minocycline Hydrochloride eent (AHFS DI)
- Arestin (FDA)
- Minocycline (FDA)
- Minocycline Capsules (FDA)
- Minocycline Extended Release Tablets (FDA)
- Minocycline Tablets (FDA)
- Minocycline (Wolters Kluwer)
Search Again
